A Research Study Looking at Similarity Between Tirzepatide Versions for Different Injection Devices
Status:
Not yet recruiting
Trial end date:
2023-07-22
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to look at the amount of the study drug, tirzepatide, that
gets into the blood stream and how long it takes the body to get rid of it when given using
two different devices. The study will also evaluate the safety and tolerability of
tirzepatide and information about any side effects experienced will be collected. For each
participant, the total duration of the study will be approximately 14 weeks, including
screening.